Lonza

Lonza is a dedicated Contract Development and Manufacturing Organization (CDMO) serving the global healthcare industry, helping pharmaceutical, biotech, and nutrition companies bring life-enhancing and life-saving treatments to market. Founded in Switzerland in 1897, Lonza is recognized as the first and original CDMO, and today stands as one of the world's largest healthcare manufacturing organizations, uniting a team of 20,000 colleagues across five continents.

Driven by a purpose to turn customers' breakthrough innovations into viable therapies, Lonza combines cutting-edge science, smart technology, and lean manufacturing to deliver integrated offerings that meet the complex needs of a global customer community. The company operates across a broad range of modalities, from traditional small molecules to advanced biologics and emerging next-generation technologies.

Core Service Offerings

• Integrated Biologics: End-to-end solutions designed to accelerate and de-risk the path to market, encompassing mammalian cell development, manufacturing, and licensing technologies.
• Advanced Synthesis: Leveraging over 125 years of chemistry expertise, Lonza delivers high-quality small molecules, highly potent active pharmaceutical ingredients (HPAPIs), and bioconjugates to support drug development programs.
• Specialized Modalities: Operating at the forefront of emerging technologies, including mRNA, cell and gene therapy (CGT), and microbial platforms, to pioneer breakthrough medicines for customers.
• Capsules & Health Ingredients: A portfolio of innovative capsules and science-backed health ingredients serving both the pharmaceutical and nutraceutical markets.

Company Scale and Global Presence

• Founded in 1897 in Switzerland, making Lonza the original CDMO in the industry.
• A global workforce of approximately 20,000 employees operating across five continents.
• Publicly listed on the SIX Swiss Exchange under the ticker LONN.SW.
• Serves a broad customer base spanning pharmaceutical, biotechnology, and nutrition sectors.

Mission, Values, and Sustainability

• Vision: To be the pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing.
• Purpose: To turn customers' breakthrough innovations into viable therapies and manufacture the medicines of tomorrow.
• Core Values: Integrity, Collaboration, Passion, Accountability, and Excellence.
• Lonza maintains an active sustainability program with defined targets and performance reporting available to stakeholders.
• The company provides dedicated investor relations resources, including financial results, stock information, and investor events.

As a fully dedicated CDMO, Lonza's integrated capabilities across biologics, small molecules, specialized modalities, and health ingredients position it as a comprehensive partner for life sciences organizations seeking to advance and commercialize innovative therapies at scale.